Why do similar product recommendations appear on test results for different patients?
Many of the suggested protocols NeuroScience includes in the laboratory reports begin Phase 1 with similar products due to the fact that we only carry handful of Phase 1 products that are specifically designed to boost inhibitory support. Observations by NeuroScience suggest that in order to more successfully address a patient’s neurotransmitter profile and seek symptom resolution that the inhibitory neurotransmitters be addressed first (in most cases). When the tool box only consists of 4-5 different products there is a likelihood that the same products will appear quite frequently. Questions regarding protocol structure can be directed to Technical Support by a healthcare provider.
